Cargando…

Long-term survival after sequential local treatments for oligometastatic esophageal squamous cell carcinoma: A case report

• Oligometastatic disease (OMD) is associated with favorable tumor biology. • Local treatment for OMD may improve overall survival (OS). • Treatment for OMD is highly complex and requires a multidisciplinary team.

Detalles Bibliográficos
Autores principales:	Kroese, Tiuri E., van Rossum, Peter S.N., van der Horst, Sylvia, Mook, Stella, Haj Mohammad, Nadia, Ruurda, Jelle P., van Hillegersberg, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403207/ https://www.ncbi.nlm.nih.gov/pubmed/35870217 http://dx.doi.org/10.1016/j.ijscr.2022.107423

Ejemplares similares

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

ASO Author Reflections: Preoperative Selection of cT4b Esophageal Cancer Patients Who Benefit From a Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE)
por: Defize, Ingmar L., et al.
Publicado: (2020)

Technical Feasibility of TachoSil Application on Esophageal Anastomoses
por: Haverkamp, Leonie, et al.
Publicado: (2015)

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer
por: Visser, E., et al.
Publicado: (2016)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study
por: Defize, Ingmar L., et al.
Publicado: (2023)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

Safety and feasibility of minimally invasive surgical interventions for esophageal and gastric cancer in the acute setting: a nationwide cohort study
por: Borggreve, Alicia S., et al.
Publicado: (2020)

A robust semi-automatic delineation workflow using denoised diffusion weighted magnetic resonance imaging for response assessment of patients with esophageal cancer treated with neoadjuvant chemoradiotherapy
por: den Boer, Robin, et al.
Publicado: (2023)

Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer
por: Borggreve, Alicia S., et al.
Publicado: (2019)

Prognostic gene expression profiling in esophageal cancer: a systematic review
por: Visser, Els, et al.
Publicado: (2016)

A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study
por: Brenkman, Hylke J. F., et al.
Publicado: (2017)

Wireless Remote Home Monitoring of Vital Signs in Patients Discharged Early After Esophagectomy: Observational Feasibility Study
por: Breteler, Martine J M, et al.
Publicado: (2020)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma
por: Shi, Zhenguo, et al.
Publicado: (2022)

Robotic-assisted gastrectomy for gastric cancer: a European perspective
por: van Boxel, Gijsbert I., et al.
Publicado: (2019)

Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands
por: Brenkman, H. J. F., et al.
Publicado: (2017)

Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer
por: Duan, Yanan, et al.
Publicado: (2023)

Diagnostic performance of a CT-based scoring system for diagnosis of anastomotic leakage after esophagectomy: comparison with subjective CT assessment
por: Goense, Lucas, et al.
Publicado: (2017)

Cervical ultrasonography has no additional value over negative (18)F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer
por: Goense, Lucas, et al.
Publicado: (2017)

State of the art in esophagectomy: robotic assistance in the abdominal phase
por: de Groot, Eline M., et al.
Publicado: (2020)

Survival and prognostic factors in oligometastatic breast cancer
por: van Ommen-Nijhof, Annemiek, et al.
Publicado: (2022)

A Step-Wise Approach to Total Laparoscopic Gastrectomy with Jejunal Pouch Reconstruction: How and Why We Do It
por: Brenkman, Hylke J. F., et al.
Publicado: (2016)

Management of anastomotic leakage after robot-assisted minimally invasive esophagectomy with an intrathoracic anastomosis
por: de Groot, Eline M, et al.
Publicado: (2023)

Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer
por: Boone, Judith, et al.
Publicado: (2016)

Trends in surgical techniques for the treatment of esophageal and gastroesophageal junction cancer: the 2022 update
por: de Groot, E M, et al.
Publicado: (2023)

Expectations of Continuous Vital Signs Monitoring for Recognizing Complications After Esophagectomy: Interview Study Among Nurses and Surgeons
por: van Rossum, Mathilde, et al.
Publicado: (2021)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
por: van der Sluis, Pieter C, et al.
Publicado: (2012)

Postoperative complications and weight loss following jejunostomy tube feeding after total gastrectomy for advanced adenocarcinomas
por: Brenkman, Hylke J.F., et al.
Publicado: (2017)

Identification of the clinically most relevant postoperative complications after gastrectomy: a population-based cohort study
por: Gertsen, Emma C., et al.
Publicado: (2019)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review
por: Brenkman, H. J. F., et al.
Publicado: (2019)

Perceived facilitators and barriers by esophageal cancer survivors participating in a post-treatment exercise program
por: van Vulpen, Jonna K., et al.
Publicado: (2023)

Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma
por: Verhage, Roy J. J., et al.
Publicado: (2011)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

The Oncological Value of Omentectomy in Gastrectomy for Cancer
por: Haverkamp, Leonie, et al.
Publicado: (2016)

ASO Author Reflections: Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis
por: Weijs, T. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s3o7vsiomot64c0ia0m1hm2u10